Kelonia Draws Attention With In Vivo CAR-T Myeloma Data

Additional Data Will Be Presented At ASH

 
• By Alaric DeArment
  
Kelonia will present Phase I data for its in vivo CAR-T at ASH. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cell Therapies

More from Advanced Therapies